Startseite Medizin Molecular defects of the GnRH-receptor gene in Chinese patients with idiopathic hypogonadotropic hypogonadism and the severity of hypogonadism
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Molecular defects of the GnRH-receptor gene in Chinese patients with idiopathic hypogonadotropic hypogonadism and the severity of hypogonadism

  • Aws K. Fathi , Sicui Hu , Xi Fu , Shan Huang , Yan Liang , Qin Ning und Xiaoping Luo EMAIL logo
Veröffentlicht/Copyright: 13. Juli 2012

Abstract

Background: Human mutations in the gonadotropin-releasing hormone receptor (GnRHR) gene cause normosmic idiopathic hypogonadotropic hypogonadism (IHH). At least 19 different mutations have been identified in this G-protein-coupled receptor, which consist mostly of missense mutations.

Objectives: To identify and determine the frequency of mutations in the coding region of the gonadotropin-releasing hormone receptor (GnRHR) gene in forty Chinese patients with normosmic idiopathic hypogonadotropic hypogonadism (IHH) and establish genotype/phenotype correlations where possible.

Methods: The diagnosis of HH was based on absent or incomplete sexual development after 17 years of age in girls and 18 years in boys associated with low or normal levels of LH in both sexes and low levels of testosterone in males and of estradiol in females. All patients presented with a normal sense of smell in an olfactory specific test. Forty IHH patients and 40 controls were screened for mutations in the coding sequence of the GnRHR gene. The coding region of the GnRHR gene was amplified by PCR and directly sequenced.

Results: A missense mutation, serine 168 arginine (S168R), located in the fourth transmembrane domain of the GnRHR gene, was identified as being in a homozygous state in one male with complete HH. The S168R mutation has been previously shown to be a cause in the complete loss of receptor function because hormone binding to the receptor is completely impaired. In another patient, a compound heterozygous mutation (Gln106Arg and Arg262Gln) was identified in a male with partial HH. The Gln106Arg mutation is located in the first extracellular loop of GnRH-R, this mutation decreases but not does eliminate GnRH binding; while Arg262Gln mutation is located in the third extracellular loop of GnRH-R and only decreases signal transduction. A good correlation between genotype and phenotype was found in our patients. The patient, who was homozygous for the completely inactivating S168R mutation, had complete HH. In addition, the affected patient who was compound heterozygous for the Gln106Arg – Arg262Gln mutations – has partial HH.

Conclusions: GnRHR mutations can be classified into partial or complete loss of function mutations. Partially inactivating substitutions of the GnRHR frequently found in familial hypogonadotrophic hypogonadism are Q106R and R262Q. Comparison of compound heterozygous with homozygous patients suggests that their phenotype and the response to GnRH is determined by the GnRHR variant with the less severe loss of function.


Corresponding author: Xiaoping Luo, Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Received: 2012-3-23
Accepted: 2012-5-31
Published Online: 2012-07-13
Published in Print: 2012-08-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorial
  4. Obesity, adolescence, and sleep deprivation
  5. Reviews
  6. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism
  7. Pathogenesis of propylthiouracil-related hepatotoxicity in children: present concepts
  8. Images in pediatric endocrinology
  9. Adhesion of the labia minora in girls: a common disorder that is rarely considered
  10. Original articles
  11. Thyroid nodules in children and adolescents: a single institution’s experience
  12. Effects of selenium supplementation in the early stage of autoimmune thyroiditis in childhood: an open-label pilot study
  13. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method
  14. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
  15. Molecular defects of the GnRH-receptor gene in Chinese patients with idiopathic hypogonadotropic hypogonadism and the severity of hypogonadism
  16. Association of vitamin D receptor gene Cdx2 polymorphism with bone markers in Turner syndrome patients
  17. Serum 25-hydroxyvitamin D levels do not correlate with asthma severity in a case-controlled study of children and adolescents
  18. Assessment of the 21-hydroxylase deficiency and the adrenal functions in young females with Turner syndrome
  19. The association of FGF23 levels in obese adolescents with insulin sensitivity
  20. Higher postprandial serum ghrelin among African-American girls before puberty
  21. Metabolic impact of a ketogenic diet compared to a hypocaloric diet in obese children and adolescents
  22. The second report from Turkey: waist percentiles for 6–11-year-old children in Elazig Province, Eastern Anatolia
  23. Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus
  24. Adiponectin and arterial stiffness in youth with type 1 diabetes: the SEARCH for Diabetes in Youth Study
  25. Thyroid autoimmunity in 72 children with type 1 diabetes mellitus: relationship with pancreatic autoimmunity and child growth
  26. Nesfatin-1 in newborns: relationship with endocrine and metabolic and anthropometric measures
  27. How much is enough? Evaluation of adrenal function in children who undergo growth hormone stimulation test
  28. A novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism
  29. Relation among ghrelin, nutritional status, and immunity in children
  30. The histopathological effects of tamoxifen in the treatment of pubertal gynecomastia
  31. Patient reports
  32. Central precocious puberty after interpersonal transfer of testosterone gel: just a coincidence?
  33. Elevated α-fetoprotein levels in Van Wyk-Grumbach syndrome: a case report and review of literature
  34. Identification of LDLR mutations in two Chinese pedigrees with familial hypercholesterolemia
  35. Foster care and type 1 diabetes in the Bronx: a case series
  36. Primary hyperparathyroidism: fifth parathyroid intrathymic adenoma in a young patient
  37. Sturge-Weber syndrome: presentation with partial hypopituitarism
  38. Self-limiting hematuria following growth hormone provocative testing with arginine hydrochloride
  39. First case report of short-chain acyl-CoA dehydrogenase deficiency in China
  40. Ganglioneuroblastoma in a young child with Turner syndrome
  41. MODY2 caused by a novel mutation of GCK gene
  42. Variability in the age at diagnosis of diabetes in two unrelated patients with a homozygous glucokinase gene mutation
  43. Letter to the editor
  44. Understanding less than nothing: high-dose vitamin D therapy for treating vitamin D deficiency
  45. Meetings
  46. Meetings Calendar
Heruntergeladen am 7.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0087/html
Button zum nach oben scrollen